4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-037255
Options or other derivatives
- Chief Operating Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
YOUNG SCOTT · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2006-06-14 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +25,000 | 25,000 | D |
Loading xslF345X02/rrd121567.xml…